|
|
||||||||
1 Institute of Medical Molecular Diagnostics Ltd, Berlin, and 2 Christiane Herzog Centre, Chest Clinic Heckeshorn, Berlin, Germany
CORRESPONDENCE: E. Spitzer, Institute of Medical Molecular Diagnostics, Schoenstrasse 90, 13086, Berlin, Germany. Fax: 49 309209071. E-mail: labor@immdonline.com
Keywords: cystic fibrosis, cystic fibrosis transmembrane regulator gene mutation, oligoligation assay
Received: July 2, 2001
Accepted July 31, 2001
By using a combination of multiplex polymerase chain reaction and allelespecific labelled probes, the oligoligation assay is designed to detect known cystic fibrosis transmembrane regulator mutations. This study shows that this assay may also be useful to detect new mutations.
The second child of a family of Bosnic origin showed all the symptoms of intestinal and pulmonary manifestations of cystic fibrosis. No signal could be obtained for the allelespecific probe 1898+1G>A. This could be explained by a nearby localized sequence change that prevented polymerase chain reaction primers or oligonucleotide probes from binding to the target sequence. Indeed, sequence analysis revealed a new 1894G>T exchange (Glu587Stop). Both parents and the healthy brother carried this mutation. Thus, the index patient was homozygous for 1894G>T, which was inherited from both parents.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |